Press Releases

GlobeNewswire, Inc.

Vancouver, Canada, July 20, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (“Clearmind”) (Nasdaq: CMND), a clinical-stage biotechnology company pioneering nonhallucinogenic neuroplastogen-derived treatments for Alcohol Use Disorder (“AUD”),...

GlobeNewswire, Inc.

TEL AVIV, Israel, July 15, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that its subsidiary NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on...

GlobeNewswire, Inc.

Zeev Rotstein, M.D. Named Chairman Following Four Decades in Health System Leadership, Including 12 Years as Director General of Sheba Medical Center Zvi Joseph and Lior Buchman Join Board, Bringing Amdocs AI Governance Leadership and $320 Million...

EIN Presswire

Doctors Against Genocide (DAG) calls on healthcare to join a rolling global One Hour of Action on Wednesday from 12:00–1:00 PM local time in every country.

GlobeNewswire, Inc.

- The ASCEND-ATTR study builds on the Phase 3 ATTRibute-CM CMR substudy results previously shared here, which indicated treatment with acoramidis may improve cardiac structure and function with evidence of amyloid regression in a subset of...

GlobeNewswire, Inc.

OR YEHUDA, Israel, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Formula Systems (1985) Ltd. (Nasdaq and TASE: FORTY) (“Formula” or the “Company”), a global information technology group providing a broad range of software, proprietary and non-proprietary...

EIN Presswire

As Jewish National Fund-USA marks 125 years, the nation's largest annual gathering of Zionists will look ahead to the next century of impact.

GlobeNewswire, Inc.

NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ARS Pharmaceuticals, Inc. (“ARS” or the “Company”) (NASDAQ: SPRY). Such investors are advised to contact Danielle Peyton at...

Illinois House Democratic Caucus

BERWYN, Ill. — Rep. Abdelnasser Rashid (D-Bridgeview) issued the following statement in response to a majority of U.S. House Democrats voting in favor of Rep. Massie’s amendment to strike $3.3 billion in funding for the Israeli military from the...

GlobeNewswire, Inc.

NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ionis Pharmaceuticals, Inc. (“Ionis” or the “Company”) (NASDAQ: IONS). Such investors are advised to contact Danielle Peyton at...

GlobeNewswire, Inc.

EUR ~8M grant supports the late-stage clinical development of Omnix’s antimicrobial OMN6 Leading European partners join forces to advance OMN6 for the treatment of life-threatening hospital-acquired infections JERUSALEM, Israel, July 13, 2026 --...

EIN Presswire

We believe Gartner recognition highlights the critical market need for runtime policy control over what every identity can access, do, and expose TEL AVIV, ISRAEL, August 20, 2026 /⁨EINPresswire.com⁩/ -- PlainID, the market-leading Runtime...

GlobeNewswire, Inc.

FDA grant of RMAT designation to Allocetra™ reinforces the potential of this program to deliver a meaningful, disease-modifying impact in age-related primary knee osteoarthritis, where patients face declined quality-of-life and limited treatment...

EIN Presswire

The Vanilla Bean Market is projected to reach USD 3.33 billion by 2035, driven by natural flavors, premiumization, traceability, and expanding extract demand.

GlobeNewswire, Inc.

ENvue Targeting Combined $10 Billion+ Enteral Feeding and Vascular Access Market Opportunity* ENvue Drive™ Demonstration Marks First Step Toward a New Generation of Intelligent Bedside Procedures and Integrates ENvue’s Proprietary AI Navigation...

GlobeNewswire, Inc.

Combined company plans to advance nebokitug, a first-in-class anti-CCL24 antibody, through a precision medicine Phase 2 trial in rheumatoid arthritis (RA) by leveraging Scipher’s AI Network Medicine platform designed to reduce risk and...

GlobeNewswire, Inc.

Company intends to accelerate the rehabilitation of Canndoc’s flagship Nir Oz facility, supporting a return to full production and the Company’s expansion in the growing German medical cannabis market NEW YORK and HERZLIYA, Israel, Aug. 24, 2026...

EIN Presswire

Advances in neuromodulation are challenging conventional approaches and expanding non‑drug treatment options for depression and other mental health conditions BURLINGTON, MA, UNITED STATES, July 7, 2026 /⁨EINPresswire.com⁩/ -- BrainsWay Ltd....

EIN Presswire

The integration enables streaming of the patient’s NOL-Nociception Level Index® data to EHRs, supporting personalized analgesia in surgery and critical care.

GlobeNewswire, Inc.

The purchase order, valued at approximately $0.3 million (NIS 1.0 million), expands Odysight.ai’s operational portfolio and may lead to wide deployment across the Israeli Defense Forces upon successful completion Ramat Gan, Israel, July 08, 2026...